Nektar Therapeutics
Price & Volume
Stats
See more52W Range | $27.87-$109 |
Market Cap | $2.5B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $54.5M |
Revenue Growth (YoY) | -9.3% |
Gross Profit (12 Mos) | $54.5M |
Diluted EPS | -$6.12 |
News
See moreYahoo Finance • yesterday
Nektar’s (NKTR) Billion-Dollar Balance Sheet Faces A Multi-Year Test
Yahoo Finance • 15 days ago
Nektar outlines REZPEG Phase III timeline with mid-2028 data and 2029 BLA plan
Yahoo Finance • 19 days ago
Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more
Yahoo Finance • 2 months ago
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
About
CEO | Mr. Howard W. Robin |
CFO | Ms. Linda M. Rubinstein M.A. |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |